Cargando…

Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis

OBJECTIVES: Our objects was to estimate the direct healthcare costs of type 2 diabetes mellitus (T2DM) in France in 2013. METHODS: Data were drawn from a random sample of ≈600,000 patients registered in the French national health insurances database, which covers 90% of the French population. An alg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charbonnel, Bernard, Simon, Dominique, Dallongeville, Jean, Bureau, Isabelle, Dejager, Sylvie, Levy-Bachelot, Laurie, Gourmelen, Julie, Detournay, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972121/ https://www.ncbi.nlm.nih.gov/pubmed/29623622 http://dx.doi.org/10.1007/s41669-017-0050-3

Ejemplares similares

Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study
por: Roussel, Ronan, et al.
Publicado: (2016)

Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database
por: Emery, Corinne, et al.
Publicado: (2020)

Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France
por: Pourcher, Valérie, et al.
Publicado: (2020)

Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database
por: Bouée, Stéphane, et al.
Publicado: (2016)

Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database
por: Detournay, Bruno, et al.
Publicado: (2015)

The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological Study
por: Balkau, Beverley, et al.
Publicado: (2017)

Hospital costs of Balloon Pulmonary Angioplasty (BPA) procedure and management for CTEPH patients: An observational study based on the French national hospital discharge database (PMSI)
por: Cottin, Vincent, et al.
Publicado: (2021)

Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study
por: Simon, Dominique, et al.
Publicado: (2014)

Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study
por: Halimi, Serge, et al.
Publicado: (2013)

Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
por: Detournay, Bruno, et al.
Publicado: (2020)

Cost analysis of adverse events associated with non-small cell lung cancer management in France
por: Chouaid, Christos, et al.
Publicado: (2017)

Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan
por: Tokunaga, Kengo, et al.
Publicado: (2021)

Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Ogino, Mieko, et al.
Publicado: (2017)

Healthcare Costs of Osteoporotic Fracture in Korea: Information from the National Health Insurance Claims Database, 2008-2011
por: Kim, Ha Young, et al.
Publicado: (2017)

Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 Diabetes
por: Roussel, Ronan, et al.
Publicado: (2020)

Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France
por: Maunoury, Franck, et al.
Publicado: (2018)

Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data
por: Tranby, Eric P., et al.
Publicado: (2022)

Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database
por: Weil-Olivier, Catherine, et al.
Publicado: (2021)

Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
por: Francis-Sedlak, Megan, et al.
Publicado: (2020)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

The association between asthma control, health care costs, and quality of life in France and Spain
por: Doz, Marianne, et al.
Publicado: (2013)

Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Kawachi, Izumi, et al.
Publicado: (2019)

Hospital Claims and the Insurance Surplus
Publicado: (1921)

The Economic Burden of Stroke Based on South Korea’s National Health Insurance Claims Database
por: Cha, Yu-Jin
Publicado: (2018)

Development of algorithms for identifying patients with Crohn’s disease in the Japanese health insurance claims database
por: Morikubo, Hiromu, et al.
Publicado: (2021)

Incidence of Mumps Deafness in Japan, 2005–2017: Analysis of Japanese Insurance Claims Database
por: Takagi, Akira, et al.
Publicado: (2022)

Data resource profile: JMDC claims database sourced from health insurance societies
por: Nagai, Katsuhiko, et al.
Publicado: (2021)

Death at no cost? Persons with no health insurance claims in the last year of life in Switzerland
por: Panczak, Radoslaw, et al.
Publicado: (2018)

The Hidden Cost of the Opioid Epidemic in the United States: Drug Screening in Insurance Claims
por: Day-Storms, Jeremy J., et al.
Publicado: (2021)

Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: Analysis of claims-based databases, 2006–2010
por: Krishnarajah, Girishanthy, et al.
Publicado: (2014)

Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage
por: Kimura, Shinya, et al.
Publicado: (2010)

Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)

Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis
por: REINHARDT, Maximilian, et al.
Publicado: (2021)

Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
por: Hu, Eric, et al.
Publicado: (2023)

The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases
por: Ramcharran, Darmendra, et al.
Publicado: (2023)

Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database
por: Bianchini, Monica L., et al.
Publicado: (2023)

Relationship Between the Number of Occlusal Supporting and Medical Cost: Analysis Using Large Claims Database from Employee Health Care Insurance in Japan
por: Murata, Tatsunori, et al.
Publicado: (2020)

Direct health care cost of treatment and medication of biliary atresia patients using the National Database of Health Insurance Claims and Specific Health Checkups
por: Hoshino, Eri, et al.
Publicado: (2022)

Unemployment insurance claims and COVID-19
por: Sjoquist, David, et al.
Publicado: (2021)

Analysis and Breakdown of Overall 1-Year Costs Relative to Inpatient and Outpatient Care Among Rheumatoid Arthritis Patients Treated with Biotherapies Using Health Insurance Claims Database in Alsace
por: Beck, Morgane, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lpj1n271ppiqpajncogl21engo